Syncom Formulations (India) Limited
Syncom Formulations (India) Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: SYNCOMF and BSE: 524470 (ISIN INE312C01025).
It has a market capitalisation of ₹2,013 crore, a last close of ₹21.41 on 2026-10-19, a one-year return of 30.8%.
Valuation: a price-to-book ratio of 4.85x, a dividend yield of 0.5%.
Profitability: return on equity of 0.0%, return on capital employed of 26.1%, an operating margin of 17.6%.
Growth: sales growth of 29.7% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.00x, promoter holding of 50.6%.
| Metric | Value |
|---|---|
| Market capitalisation | 2,013 |
| Last close | ₹21.41 |
| P/B | 4.85x |
| Dividend yield | 0.5% |
| ROE (FY) | 0.0% |
| ROCE (FY) | 26.1% |
| Operating margin (TTM) | 17.6% |
| Sales growth, 3-year CAGR | 29.7% |
| Debt / equity | 0.00x |
| Promoter holding | 50.6% |
| 1-year return | 30.8% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means